L. Minicucci

963 total citations
39 papers, 562 citations indexed

About

L. Minicucci is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, L. Minicucci has authored 39 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Genetics. Recurrent topics in L. Minicucci's work include Cystic Fibrosis Research Advances (22 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Diabetes Management and Research (5 papers). L. Minicucci is often cited by papers focused on Cystic Fibrosis Research Advances (22 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Diabetes Management and Research (5 papers). L. Minicucci collaborates with scholars based in Italy, United States and Japan. L. Minicucci's co-authors include Renata Lorini, Rosaria Casciaro, G. Manno, A. De Alessandri, Patrizia Morelli, Luca Romano, Carla Colombo, A. Giannattasio, Federico Cresta and Vincenzo Carnovale and has published in prestigious journals such as Gastroenterology, PLoS ONE and Diabetes Care.

In The Last Decade

L. Minicucci

39 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Minicucci Italy 15 326 111 77 69 68 39 562
Patrizia Morelli Italy 13 197 0.6× 177 1.6× 41 0.5× 61 0.9× 17 0.3× 29 504
James E. Rogers United States 11 106 0.3× 127 1.1× 44 0.6× 26 0.4× 124 1.8× 18 664
Adelaida Lamas Spain 11 260 0.8× 178 1.6× 37 0.5× 64 0.9× 26 0.4× 24 539
Alejandro Díaz United States 16 77 0.2× 101 0.9× 43 0.6× 45 0.7× 67 1.0× 60 615
Joachim Schmitt Germany 9 123 0.4× 226 2.0× 189 2.5× 30 0.4× 70 1.0× 14 934
Lu-Quan Li China 14 166 0.5× 162 1.5× 20 0.3× 17 0.2× 109 1.6× 53 556
María Tamayo Spain 15 128 0.4× 137 1.2× 52 0.7× 97 1.4× 74 1.1× 26 800
Stavroula Ilia Greece 12 115 0.4× 133 1.2× 23 0.3× 16 0.2× 26 0.4× 49 464
K Murono Japan 13 63 0.2× 119 1.1× 62 0.8× 33 0.5× 30 0.4× 43 466
Meg Kays United States 9 72 0.2× 153 1.4× 35 0.5× 97 1.4× 31 0.5× 16 396

Countries citing papers authored by L. Minicucci

Since Specialization
Citations

This map shows the geographic impact of L. Minicucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Minicucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Minicucci more than expected).

Fields of papers citing papers by L. Minicucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Minicucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Minicucci. The network helps show where L. Minicucci may publish in the future.

Co-authorship network of co-authors of L. Minicucci

This figure shows the co-authorship network connecting the top 25 collaborators of L. Minicucci. A scholar is included among the top collaborators of L. Minicucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Minicucci. L. Minicucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amato, Annalisa, Fabio Majo, Gianluca Ferrari, et al.. (2018). [Italian Cystic Fibrosis Registry. Report 2011-2014].. PubMed. 42(1S1). 1–32. 8 indexed citations
2.
Stefani, Stefania, S. Campana, Lisa Cariani, et al.. (2017). Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis. International Journal of Medical Microbiology. 307(6). 353–362. 65 indexed citations
3.
Averna, Monica, Federico Cresta, Marco Pedrazzi, et al.. (2016). Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients. Archives of Biochemistry and Biophysics. 604. 103–112. 13 indexed citations
4.
Manniello, Michele Dario, Olga Zegarra‐Moran, Luis J. V. Galietta, et al.. (2016). Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(4). 337–345. 31 indexed citations
5.
Averna, Monica, Roberto Stifanese, Roberta De Tullio, et al.. (2011). Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(12). 1649–1657. 10 indexed citations
6.
Minicucci, L., Rosaria Casciaro, A. De Alessandri, et al.. (2011). Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. Pediatric Diabetes. 13(2). 197–202. 23 indexed citations
7.
Buzzetti, Roberto, Gianfranco Alicandro, L. Minicucci, et al.. (2011). Validation of a predictive survival model in Italian patients with cystic fibrosis. Journal of Cystic Fibrosis. 11(1). 24–29. 29 indexed citations
8.
Tosca, Maria Angela, Elisa Villa, Michela Silvestri, et al.. (2008). Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. Pediatric Allergy and Immunology. 20(4). 385–391. 15 indexed citations
9.
Minicucci, L., Renata Lorini, A. Giannattasio, et al.. (2007). Liver disease as risk factor for cystic fibrosis‐related diabetes development. Acta Paediatrica. 96(5). 736–739. 28 indexed citations
10.
Locatelli, Mattia, Raffaella Buzzetti, Andrea Galgani, et al.. (2007). Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). Diabetic Medicine. 24(8). 916–919. 10 indexed citations
11.
Prisco, Francesco, Antonio Picardi, Dario Iafusco, et al.. (2006). Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatric Diabetes. 7(4). 223–228. 29 indexed citations
12.
Lorini, Renata, L. Minicucci, Flavia Napoli, et al.. (2005). Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data.. PubMed. 76 Suppl 3. 31–5. 7 indexed citations
13.
Minicucci, L., et al.. (2005). Beta-cell Autoantibodies and Diabetes Mellitus Family History in Cystic Fibrosis. Journal of Pediatric Endocrinology and Metabolism. 18(8). 755–60. 19 indexed citations
14.
Minicucci, L., et al.. (2003). Impact of inhaled corticosteroids on the risk of early Pseudomonas aeruginosa acquisition in cystic fibrosis. Acta Paediatrica. 92(6). 684–687. 1 indexed citations
15.
Lorini, Renata, et al.. (2001). [The adolescent with type 1 diabetes mellitus].. PubMed. 53(5). 375–80. 1 indexed citations
16.
Scholz, Richard W., L. Minicucci, & C. Channa Reddy. (1997). Effects of vitamin E and selenium on antioxidant defense in rat heart. IUBMB Life. 42(5). 997–1006. 17 indexed citations
17.
Minicucci, L., et al.. (1995). Uncommon presenting manifestations of cystic fibrosis: A clinical alert. Pädiatrie & Pädologie. 30(1). 1–7. 2 indexed citations
18.
Girosi, Donata, et al.. (1992). USO DELL'OFLOXACIN NEI PAZIENTI CON FIBROSI CISTICA. 44(3). 79–86. 2 indexed citations
19.
Minicucci, L., et al.. (1991). DISCHARGE REPORT ACCURACY. International Journal for Quality in Health Care. 3(4). 263–265. 4 indexed citations
20.
Romano, Claudio, et al.. (1984). [Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience].. PubMed. 36(3). 127–38. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026